Manuel Lubinus, MSU Chief Science Officer, reflects on the progress and unmet needs in myositis research.

Chief Science Officer 

Manuel holds a Ph.D. in Immunology and has dedicated over a decade to basic research, focusing on the signaling pathways involved in autoimmune diseases. His career also encompasses roles in business development, where he gained significant experience in the vaccine sector, as well as in pharmaceuticals and medical devices.

Following his diagnosis with Myositis, Manuel was drawn to join Myositis Support and Understanding (MSU). He was particularly attracted by MSU's commitment to integrating the patient perspective and fostering meaningful research partnerships.